114 patients with genital herpes(GH)divided into three groups at random were treated separately with acyclovir(ACV,0.8g daily orally),interferon(IFN,one million u.in.)and routine external therapy,such as 3% boric aci...114 patients with genital herpes(GH)divided into three groups at random were treated separately with acyclovir(ACV,0.8g daily orally),interferon(IFN,one million u.in.)and routine external therapy,such as 3% boric acid solution or 0.1% rivanol solution.There was no difference in age and time of onset between these three groups.The effect of drugs was observed at the fourth and eighth days of treatment.A definite effectiveness was manifested in 10(37%)and 21 cases(77.8%)in ACV group,14(48.3%)and 25 cases(86.2%)in IFN group,and only 9(6.9%)and 13cases(22.4%)in routine therapy group.Statistical analysis revealed that ACV and IFN were much mor effective than routine therapy in terms of shortened course and symptoms relieved(P<0.05),but they could not prevent the recurrence of CH.展开更多
目的研究乌骨藤苷晶体对人宫颈腺癌荷瘤裸鼠肿瘤的抑制作用。方法采用人宫颈腺癌接种裸鼠待长出实体瘤,用第三代实体瘤移植裸鼠皮下建立人宫颈腺癌裸鼠模型;用乌骨藤提取物苷晶体(I、II)(0.24 g/250 m L)分别给实验组裸鼠灌胃0.5 m L/只...目的研究乌骨藤苷晶体对人宫颈腺癌荷瘤裸鼠肿瘤的抑制作用。方法采用人宫颈腺癌接种裸鼠待长出实体瘤,用第三代实体瘤移植裸鼠皮下建立人宫颈腺癌裸鼠模型;用乌骨藤提取物苷晶体(I、II)(0.24 g/250 m L)分别给实验组裸鼠灌胃0.5 m L/只,对照组给饮用水,每日1次,连续30 d。每周测量体质量和肿瘤大小2次,30 d给药后处死小鼠,解剖,称其肿瘤质量,计算抑瘤率,评价乌骨藤提取物苷晶体(Ⅰ、Ⅱ)对裸鼠荷瘤的抑制作用。结果乌骨藤苷晶体Ⅰ和晶体Ⅱ对人宫颈腺癌荷瘤裸鼠有抑制肿瘤作用,抑瘤率分别88.95%和66.71%,其中晶体Ⅰ和Ⅱ抑制肿瘤作用与对照组比较有显著性差异(晶体Ⅰ,P<0.01;晶体Ⅱ,P<0.05)。结论乌骨藤苷晶体Ⅰ和晶体Ⅱ均有抑制人宫颈腺癌荷瘤裸鼠肿瘤的作用。展开更多
文摘114 patients with genital herpes(GH)divided into three groups at random were treated separately with acyclovir(ACV,0.8g daily orally),interferon(IFN,one million u.in.)and routine external therapy,such as 3% boric acid solution or 0.1% rivanol solution.There was no difference in age and time of onset between these three groups.The effect of drugs was observed at the fourth and eighth days of treatment.A definite effectiveness was manifested in 10(37%)and 21 cases(77.8%)in ACV group,14(48.3%)and 25 cases(86.2%)in IFN group,and only 9(6.9%)and 13cases(22.4%)in routine therapy group.Statistical analysis revealed that ACV and IFN were much mor effective than routine therapy in terms of shortened course and symptoms relieved(P<0.05),but they could not prevent the recurrence of CH.
文摘目的研究乌骨藤苷晶体对人宫颈腺癌荷瘤裸鼠肿瘤的抑制作用。方法采用人宫颈腺癌接种裸鼠待长出实体瘤,用第三代实体瘤移植裸鼠皮下建立人宫颈腺癌裸鼠模型;用乌骨藤提取物苷晶体(I、II)(0.24 g/250 m L)分别给实验组裸鼠灌胃0.5 m L/只,对照组给饮用水,每日1次,连续30 d。每周测量体质量和肿瘤大小2次,30 d给药后处死小鼠,解剖,称其肿瘤质量,计算抑瘤率,评价乌骨藤提取物苷晶体(Ⅰ、Ⅱ)对裸鼠荷瘤的抑制作用。结果乌骨藤苷晶体Ⅰ和晶体Ⅱ对人宫颈腺癌荷瘤裸鼠有抑制肿瘤作用,抑瘤率分别88.95%和66.71%,其中晶体Ⅰ和Ⅱ抑制肿瘤作用与对照组比较有显著性差异(晶体Ⅰ,P<0.01;晶体Ⅱ,P<0.05)。结论乌骨藤苷晶体Ⅰ和晶体Ⅱ均有抑制人宫颈腺癌荷瘤裸鼠肿瘤的作用。
